Kestra Private Wealth Services LLC Buys 1,206 Shares of Stryker Co. (NYSE:SYK)

Kestra Private Wealth Services LLC raised its stake in shares of Stryker Co. (NYSE:SYK) by 6.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 19,064 shares of the medical technology company’s stock after acquiring an additional 1,206 shares during the period. Kestra Private Wealth Services LLC’s holdings in Stryker were worth $6,864,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Howland Capital Management LLC raised its holdings in shares of Stryker by 9.5% in the fourth quarter. Howland Capital Management LLC now owns 87,461 shares of the medical technology company’s stock valued at $31,564,000 after purchasing an additional 7,611 shares during the last quarter. Birch Hill Investment Advisors LLC grew its position in Stryker by 29.5% in the 4th quarter. Birch Hill Investment Advisors LLC now owns 795 shares of the medical technology company’s stock worth $286,000 after purchasing an additional 181 shares in the last quarter. Entropy Technologies LP purchased a new stake in Stryker in the 4th quarter valued at about $236,000. Empowered Funds LLC lifted its position in shares of Stryker by 17.5% during the 4th quarter. Empowered Funds LLC now owns 7,644 shares of the medical technology company’s stock worth $2,752,000 after buying an additional 1,140 shares in the last quarter. Finally, Kingsview Wealth Management LLC boosted its stake in shares of Stryker by 1.4% in the 4th quarter. Kingsview Wealth Management LLC now owns 14,318 shares of the medical technology company’s stock worth $5,155,000 after buying an additional 200 shares during the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on SYK. Evercore ISI increased their price target on Stryker from $380.00 to $384.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. The Goldman Sachs Group lifted their target price on Stryker from $384.00 to $427.00 and gave the stock a “neutral” rating in a research note on Thursday, January 30th. Robert W. Baird boosted their price target on shares of Stryker from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. JMP Securities restated a “market perform” rating on shares of Stryker in a report on Tuesday, January 7th. Finally, Morgan Stanley upgraded shares of Stryker from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $370.00 to $445.00 in a research note on Monday, December 2nd. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $419.37.

Stryker Price Performance

Stryker stock opened at $391.42 on Monday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The firm has a market capitalization of $149.22 billion, a P/E ratio of 50.44, a PEG ratio of 2.98 and a beta of 0.96. The business has a fifty day moving average price of $377.23 and a 200-day moving average price of $364.97.

Stryker (NYSE:SYK) last posted its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, beating analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the firm posted $3.46 earnings per share. As a group, equities research analysts forecast that Stryker Co. will post 13.49 EPS for the current year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Monday, March 31st will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.86%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s dividend payout ratio is presently 43.30%.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the sale, the director now owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.